SCHEMBL8911614

SCHEMBL8911614

O=CN1c2ccccc2C=Cc2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
SCN4A P35499 1/20 0.47
SCN5A Q14524 1/20 0.47
SCN9A Q15858 1/20 0.47
P2RX4 Q99571 15/20 0.44
P2RX1 P51575 5/20 0.41
P2RX3 P56373 5/20 0.41
P2RX7 Q99572 2/20 0.41
PTBP1 P26599 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MTNR1A P48039 2/20 0.37
MTNR1B P49286 2/20 0.37
TLR9 Q9NR96 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16808018 0.84 P2RX4 (0.49) LMNATSHRMAPK1SCN4ASCN5A
SCHEMBL20353763 0.76 LMNA (0.42) LMNATSHRMAPK1SCN4ASCN5A
SCHEMBL11088295 0.71 P2RX4 (0.43) LMNATSHRMAPK1SCN4ASCN5A
SCHEMBL19733503 0.70 HSD17B3 (0.39) LMNATSHRMAPK1SCN4ASCN5A
SCHEMBL627990 0.70 MAOA (0.52) LMNA
SCHEMBL9179488 0.70 HPGD (0.42) LMNATSHRSMN1; SMN2
SCHEMBL9036500 0.70 MEN1 (0.47) TSHRSMN1; SMN2
SCHEMBL11739419 0.70 P2RX4 (0.48) P2RX4P2RX1P2RX3SMN1; SMN2NPSR1
SCHEMBL3453648 0.69 LMNA (0.36) LMNATSHRMAPK1SCN4ASCN5A
SCHEMBL30466762 0.68 LMNA (0.48) LMNATSHRMAPK1SCN4ASCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9024053-B2 Compound obtained by dimerizing with light irradiation, a compound containing a group having lyophilicity, and a compound containing a group having liquid-repellency JOLED INC. (JP) 2015-05-05 US disclosed
US-8847211-B2 Device, thin film transistor, method for manufacturing the device and method for manufacturing the thin film transistor PANASONIC CORPORATION (JP) 2014-09-30 US disclosed
US-7875467-B2 Chemiluminescence; quantitative analysis of macromolecules; complexing sample to acridinium compound, labels for improving sensitivity of immunoassays, 2',6'-dimethyl-4'-N-succinimidyloxycaproyl-amidocarbonylphenyl-N10-2,7-tris[O-methoxyhexa(ethylene) glycol-sulfonamidylpropyl]-acridinium-9-carboxylate SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) 2011-01-25 US disclosed
US-20080305557-A1 Novel Applications of Acridinium Compounds and Derivatives in Homogeneous Assays SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS (US) 2008-12-11 US disclosed
US-5622953-A DRUG RESISTANT TO ANTICANCER CHEMOTHERAPEUTIC DRUG BASF AKTIENGESELLSCHAFT (DE) 1997-04-22 US disclosed
EP-0691962-A1 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE BASF AKTIENGESELLSCHAFT (DE) 1996-01-17 EP disclosed
US-5405843-A Anticancer drug potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-04-11 US disclosed
EP-0363212-B1 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS (JP) 1995-01-04 EP disclosed
US-5204348-A Quinoline derivatives MITSUI TOATSU CHEMICALS INC. (JP) 1993-04-20 US disclosed
US-5112817-A Anticancer Drug Potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-05-12 US disclosed
EP-0363212-A2 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-04-11 EP disclosed
US-3992370-A 1,1-Dichloro-1a,1b-dihydrodibenzo(b,f)cycloprop(d)azepine-6(1H)-carboxaldehyde TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1976-11-16 US disclosed